Skip to main content

W P97 Pill - pink round, 11mm

Pill with imprint W P97 is Pink, Round and has been identified as Primaquine Phosphate 26.3 mg (15 mg base). It is supplied by Sanofi-Aventis.

Primaquine is used in the treatment of Malaria; Malaria Prevention; Pneumocystis Pneumonia and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 26.3 mg (15 mg base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for W P97

Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97
Primaquine phosphate 26.3 mg (15 mg base) W P97

Primaquine Phosphate

Imprint
W P97
Strength
26.3 mg (15 mg base)
Color
Pink
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimalarial quinolines
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sanofi-Aventis
Inactive Ingredients
carnauba wax, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, polysorbate 80, ferric oxide red, magnesium silicate, titanium dioxide, hypromellose 2910 (15000 mPa.s), corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00024-1596 Sanofi
43063-0225 (Discontinued) PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.